**Introduction to HOLO-TRANSFERRIN** HOLO-TRANSFERRIN is a high-purity, iron-saturated form of transferrin, a critical glycoprotein essential for iron transport and cellular uptake. This biologically active protein plays a vital role in maintaining iron homeostasis, supporting cell growth, and ensuring efficient iron delivery in research and biopharmaceutical applications. With exceptional stability and consistency, HOLO-TRANSFERRIN is ideal for cell culture, diagnostic assays, and therapeutic development. Its iron-binding capacity enhances cell proliferation and differentiation, making it invaluable in stem cell research, cancer studies, and regenerative medicine. Rigorously tested for purity and performance, HOLO-TRANSFERRIN ensures reliable results, making it a trusted choice for scientists and manufacturers in biotechnology and life sciences.
Preparation Process: To prepare **holo-transferrin**, dissolve **apo-transferrin** (iron-free) in a buffer (e.g., 20 mM HEPES or Tris, pH 7.4–8.0). Add a **2:1 molar ratio of ferric iron (Fe³⁺)** as **ferric ammonium citrate** or **ferric nitrilotriacetate (Fe-NTA)**. Incubate at **37°C for 1–2 hours** with gentle agitation. Ensure **bicarbonate (5–10 mM)** is present to facilitate iron binding. Remove excess iron via **dialysis** (against buffer) or **gel filtration chromatography**. Confirm iron saturation using **UV-Vis spectroscopy** (absorbance at 465 nm). Sterilize by **0.22 µm filtration** and store at **4°C** or **–20°C**. Maintain **iron:protein ratio** for optimal functionality.
Usage Scenarios: Holo-transferrin is the iron-bound form of transferrin, a glycoprotein essential for iron transport in the bloodstream. It binds and delivers iron to cells via transferrin receptors, regulating iron homeostasis and preventing oxidative damage from free iron. Clinically, holo-transferrin is used to treat iron deficiency anemia by replenishing iron stores safely. It also serves as a biomarker for iron metabolism disorders. In research, holo-transferrin is employed to study cellular iron uptake, receptor-mediated endocytosis, and conditions like hemochromatosis or cancer, where iron metabolism is dysregulated. Additionally, it aids in drug delivery systems by targeting cells with high transferrin receptor expression.